ArticleScience (New York, N.Y.)2018

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.

Jonathan T Sockolosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.